Redsense Medical AB (publ)
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flo… Read more
Market Cap & Net Worth: Redsense Medical AB (publ) (RDSNF)
Redsense Medical AB (publ) (OTCGREY:RDSNF) has a market capitalization of $8.39 Million ($8.39 Million) as of March 19, 2026. Listed on the OTCGREY stock exchange, this USA-based company holds position #31100 globally and #10238 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Redsense Medical AB (publ)'s stock price $0.51 by its total outstanding shares 16444900 (16.44 Million).
Redsense Medical AB (publ) Market Cap History: 2023 to 2025
Redsense Medical AB (publ)'s market capitalization history from 2023 to 2025. Data shows growth from $17.27 Million to $8.39 Million (0.00% CAGR).
Redsense Medical AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Redsense Medical AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.69x
Redsense Medical AB (publ)'s market cap is 0.69 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $17.27 Million | $24.97 Million | -$4.51 Million | 0.69x | N/A |
Competitor Companies of RDSNF by Market Capitalization
Companies near Redsense Medical AB (publ) in the global market cap rankings as of March 19, 2026.
Key companies related to Redsense Medical AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Redsense Medical AB (publ) Historical Marketcap From 2023 to 2025
Between 2023 and today, Redsense Medical AB (publ)'s market cap moved from $17.27 Million to $ 8.39 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.39 Million | 0.00% |
| 2024 | $8.39 Million | -51.43% |
| 2023 | $17.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Redsense Medical AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.39 Million USD |
| MoneyControl | $8.39 Million USD |
| MarketWatch | $8.39 Million USD |
| marketcap.company | $8.39 Million USD |
| Reuters | $8.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.